Brief: Viva Biotech Says As Of Oct 13, Repurchased Aggregate Principal Amount Of $43 Mln Of Convertible Bonds

VIVA Biotech Holdings

13/10/2023 11:49

Oct 13 (Reuters) - VIVA Biotech Holdings  1873.HK :
    * AS OF OCT 13, CO REPURCHASED AGGREGATE PRINCIPAL AMOUNT OF
US$43
MILLION OF CONVERTIBLE BONDS
    * IMMEDIATELY AFTER CANCELLATION, AGGREGATE PRINCIPAL AMOUNT
OF
US$237 MILLION OF CONVERTIBLE BONDS WILL REMAIN OUTSTANDING
    * COMPANY EXPECTS TO CANCEL REPURCHASED CONVERTIBLE BONDS AS
SOON
AS POSSIBLE

Source text for Eikon:  ID:nHKS4lKwbh 
Further company coverage:  1873.HK 

 ((Reuters.Briefs@thomsonreuters.com;))